Advances in Personalized Prostate Cancer Therapy
Dr. Phillip Kantoff, a leader in prostate cancer therapy, presents an update in the personalized therapies for prostate cancer. Dr. Kantoff is the Director of the Lank Center for Genitourinary Cancer at the Dana Farber Cancer Center and Chief of Solid Tumor Oncology at Harvard University School of Medicine. Series: Jonsson Cancer Center at UCLA [9/2009] [Health and Medicine] [Professional Medical Education] [Show ID: 16931]
Advances in Personalized Prostate Cancer Therapy
Management of Prostate Cancer NEW by Eric A. Klein
 | US $226.34 End Date: Thursday May-17-2012 19:22:55 PDT Buy It Now for only: US $226.34 Buy it now | Add to watch list |
33 cents Prostate Cancer Awareness Scott# 3315
 | US $1.25 End Date: Thursday May-17-2012 20:13:57 PDT Buy It Now for only: US $1.25 Buy it now | Add to watch list |
Related posts:
- Focal therapy for prostate cancer can preserve potency
- The Best News About Radiation Therapy: Everything You Need to Know About Your Treatment
- Alternative cancer therapy, B17 (1 of 5) - GE Griffin
- Prostate Cancer: Managing a Rising PSA after Radiation Therapy
- Prostate Cancer: Managing a Rising PSA after Hormone Therapy